Statement on combined hormonal contraceptives containing third-or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism

Johannes Bitzer, Jean Jacques Amy, Rob Beerthuizen, Martin Birkhäuser, Teresa Bombas, Mitchell D Creinin, Philip D. Darney, Lisa Ferreira Vicente, Kristina Gemzell-Danielsson, Bruno Imthurn, Jeffrey T. Jensen, Andrew M. Kaunitz, Ali Kubba, Medard M. Lech, Diana Mansour, Gabriele Merki, Thomas Rabe, Katarina Sedlecki, David Serfaty, Jacques SeydouxLee P. Shulman, Regine Sitruk-Ware, Sven O. Skouby, Anne Szarewski, James Trussell, Carolyn Westhoff

Research output: Contribution to journalArticle

12 Scopus citations
Original languageEnglish (US)
Pages (from-to)143-147
Number of pages5
JournalEuropean Journal of Contraception and Reproductive Health Care
Volume18
Issue number3
DOIs
StatePublished - Jun 2013

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Pharmacology (medical)
  • Reproductive Medicine

Cite this

Bitzer, J., Amy, J. J., Beerthuizen, R., Birkhäuser, M., Bombas, T., Creinin, M. D., Darney, P. D., Vicente, L. F., Gemzell-Danielsson, K., Imthurn, B., Jensen, J. T., Kaunitz, A. M., Kubba, A., Lech, M. M., Mansour, D., Merki, G., Rabe, T., Sedlecki, K., Serfaty, D., ... Westhoff, C. (2013). Statement on combined hormonal contraceptives containing third-or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism. European Journal of Contraception and Reproductive Health Care, 18(3), 143-147. https://doi.org/10.3109/13625187.2013.792637